Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38(12):1249–63. https://doi.org/10.1007/s40618-015-0312-9.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10–26. https://doi.org/10.1038/gim.0b013e31822bead0.

CAS  Article  PubMed  Google Scholar 

Mackenzie ML, Triador L, Gill JK, et al. Dietary intake in youth with prader-willi syndrome. Am J Med Genet A. 2018;176(11):2309–17. https://doi.org/10.1002/ajmg.a.40491.

CAS  Article  PubMed  Google Scholar 

Guinovart M, Coronas R, Caixas A. Psychopathological disorders in Prader-Willi syndrome. Endocrinol Diabetes Nutr (Engl Ed). 2019;66(9):579–87. https://doi.org/10.1016/j.endinu.2019.03.004.

Article  Google Scholar 

Muscogiuri G, Barrea L, Faggiano F, et al. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches. J Endocrinol Invest. 2021;44(10):2057–70. https://doi.org/10.1007/s40618-021-01574-9.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Alsaif M, Elliot SA, MacKenzie ML, Prado CM, Field CJ, Haqq AM. Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review. Adv Nutr. 2017;8(6):905–15. https://doi.org/10.3945/an.117.016253.

Article  PubMed  PubMed Central  Google Scholar 

Krasinska A, Skowronska B. Prader-Willi Syndrome - nutritional management in children, adolescents and adults. Pediatr Endocrinol Diabetes Metab. 2017;23(2):101–106. https://doi.org/10.18544/PEDM-23.02.0080.

Bekx MT, Carrel AL, Shriver TC, Li Z, Allen DB. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr. 2003;143(3):372–6. https://doi.org/10.1067/S0022-3476(03)00386-X.

Article  PubMed  Google Scholar 

Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Int J Obes (Lond). 2012;36(12):1564–70. https://doi.org/10.1038/ijo.2011.274.

CAS  Article  Google Scholar 

Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol. 2013;2013(1):14. https://doi.org/10.1186/1687-9856-2013-14.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Noordam C, Hoybye C, Eiholzer U. Prader-Willi Syndrome and Hypogonadism: A Review Article. Int J Mol Sci. 2021;22(5). https://doi.org/10.3390/ijms22052705.

Pravdivyi I, Ballanyi K, Colmers WF, Wevrick R. Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome. Hum Mol Genet. 2015;24(15):4276–83. https://doi.org/10.1093/hmg/ddv159.

CAS  Article  PubMed  Google Scholar 

Deal CL, Tony M, Hoybye C, et al. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98(6):E1072-1087. https://doi.org/10.1210/jc.2012-3888.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Proffitt J, Osann K, McManus B, et al. Contributing factors of mortality in Prader-Willi syndrome. Am J Med Genet A. 2019;179(2):196–205. https://doi.org/10.1002/ajmg.a.60688.

Article  PubMed  Google Scholar 

Crino A, Grugni G. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome. Curr Diab Rep. 2020;20(2):7. https://doi.org/10.1007/s11892-020-1284-5.

Article  PubMed  Google Scholar 

Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader-Willi Syndrome: A systematic review of studies of morbidity and mortality. Eur J Med Genet. 2022;65(1): 104379. https://doi.org/10.1016/j.ejmg.2021.104379.

CAS  Article  PubMed  Google Scholar 

Diene G, Mimoun E, Feigerlova E, et al. Endocrine disorders in children with Prader-Willi syndrome–data from 142 children of the French database. Horm Res Paediatr. 2010;74(2):121–8. https://doi.org/10.1159/000313377.

CAS  Article  PubMed  Google Scholar 

Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, et al. Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A. 2011;155A(9):2112–2124. https://doi.org/10.1002/ajmg.a.34171.

Miller JL, Linville TD, Dykens EM. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study. J Pediatr Endocrinol Metab. 2014;27(1–2):23–9. https://doi.org/10.1515/jpem-2013-0116.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Motaghedi R, Lipman EG, Hogg JE, Christos PJ, Vogiatzi MG, Angulo MA. Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome. Eur J Med Genet. 2011;54(1):14–8. https://doi.org/10.1016/j.ejmg.2010.09.015.

Article  PubMed  Google Scholar 

Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007;369(9555):71–7. https://doi.org/10.1016/S0140-6736(07)60033-6.

CAS  Article  PubMed  Google Scholar 

Hor A, Purtell L.Influence of Naltrexone, Bupropion Combination Treatment on Body Mass Index in Prader-Willi Syndrome Re: “Prader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent” by Puri, et al. J Child Adolesc Psychopharmacol. 2016;26(9):854. https://doi.org/10.1089/cap.2016.0073.

CAS  Article  PubMed  Google Scholar 

Fintini D, Grugni G, Brufani C, Bocchini S, Cappa M, Crino A. Use of GLP-1 receptor agonists in Prader-Willi Syndrome: report of six cases. Diabetes Care. 2014;37(4):e76-77. https://doi.org/10.2337/dc13-2575.

CAS  Article  PubMed  Google Scholar 

Tan Q, Orsso CE, Deehan EC, et al. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review. Obes Rev. 2020;21(5): e12992. https://doi.org/10.1111/obr.12992.

Article  PubMed  Google Scholar 

Muscogiuri G, Formoso G, Pugliese G, et al. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications. Rev Endocr Metab Disord. 2019;20(2):239–50. https://doi.org/10.1007/s11154-019-09502-2.

Article  PubMed  Google Scholar 

Schwartz L, Caixas A, Dimitropoulos A, et al. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium. J Neurodev Disord. 2021;13(1):25. https://doi.org/10.1186/s11689-021-09373-2.

Article  PubMed  PubMed Central  Google Scholar 

Miller JL, Lynn CH, Driscoll DC, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(5):1040–9. https://doi.org/10.1002/ajmg.a.33951.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Damen L, Donze SH, Kuppens RJ, et al. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition. Orphanet J Rare Dis. 2020;15(1):163. https://doi.org/10.1186/s13023-020-01440-6.

Article  PubMed  PubMed Central  Google Scholar 

Lacroix D, Moutel S, Coupaye M, et al. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity. J Clin Endocrinol Metab. 2015;100(3):850–9. https://doi.org/10.1210/jc.2014-3127.

CAS  Article  PubMed  Google Scholar 

Tanaka Y, Abe Y, Oto Y, et al. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet A. 2013;161A(1):27–33. https://doi.org/10.1002/ajmg.a.35653.

CAS  Article  PubMed  Google Scholar 

Crino A, Fintini D, Bocchini S, Grugni G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes. 2018;11:579–93. https://doi.org/10.2147/DMSO.S141352.

CAS  Article  PubMed  PubMed Central  Google Scholar 

Hedgeman E, Ulrichsen SP, Carter S, et al. Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark. Int J Obes (Lond). 2017;41(10):1531–8. https://doi.org/10.1038/ijo.2017.139.

CAS  Article  Google Scholar 

Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M, speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(11):4183–4197. https://doi.org/10.1210/jc.2008-0649.

Pellikaan K, Rosenberg AGW, Kattentidt-Mouravieva AA, et al. Missed Diagnoses and Health Problems in Adults With Prader-Willi Syndrome: Recommendations for Screening and Treatment. J Clin Endocrinol Metab. 2020;105(12). https://doi.org/10.1210/clinem/dgaa621.

Butler MG, Swift LL, Hill JO. Fasting Plasma Lipid, Glucose, and Insulin Levels in Prader-Willi Syndrome and Obese Individuals. Dysmorphol Clin Genet. 1990;4(1):23–6.

PubMed  PubMed Central  Google Scholar 

Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab. 2011;96(1):E225-232. https://doi.org/10.1210/jc.2010-1733.

CAS  Article  PubMed  Google Scholar 

Brambilla P, Crino A, Bedogni G, et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis. 2011;21(4):269–76. https://doi.org/10.1016/j.numecd.2009.10.004.

CAS  Article  PubMed  Google Scholar 

Manzardo AM, Loker J, Heinemann J, Loker C, Butler MG. Survival trends from the Prader-Willi Syndrome Association (USA) 40-year mortality survey. Genet Med. 2018;20(1):24–30. https://doi.org/10.1038/gim.2017.92.

Article  PubMed  Google Scholar 

Schwingshackl L, Missbach B, Konig J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1292–9. https://doi.org/10.1017/S1368980014001542.

Article  PubMed  Google Scholar 

Butler MG, Theodoro M, Skouse JD. Thyroid function studies in Prader-Willi syndrome. Am J Med Genet A. 2007;143A(5):488–92. https://doi.org/10.1002/ajmg.a.31683.

CAS  Article  PubMed  PubMed Central